Literature DB >> 12598216

Desmopressin therapy for massive hemoptysis associated with severe leptospirosis.

Laurent Pea1, Laurent Roda, Véronique Boussaud, Bernard Lonjon.   

Abstract

Massive hemoptysis in patients with severe leptospirosis is often resistant to conventional therapies and can rapidly become fatal. Desmopressin is a fast-acting blood-saving agent used in various hereditary and acquired clotting disorders. We used desmopressin infusions to treat massive pulmonary hemorrhage in six leptospirosis patients with respiratory failure, shock, and multiple organ dysfunction. Hemoptysis ceased rapidly in every case, and five patients finally recovered. Two additional patients with less severe hemoptysis were also successfully treated.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12598216     DOI: 10.1164/rccm.200205-450CR

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  9 in total

1.  Parenteral use of recombinant activated factor VII during diffuse alveolar hemorrhage secondary to leptospirosis.

Authors:  Alexis Tatopoulos; Delphine Herbain; Céline Kazmierczak; Pierre-Edouard Bollaert; Sébastien Gibot
Journal:  Intensive Care Med       Date:  2010-03       Impact factor: 17.440

2.  Leptospirosis: An Unusual Cause of ARDS.

Authors:  Marc Clavel; Gwenaelle Lhéritier; Nicolas Weinbreck; Antoine Guerlin; Anthony Dugard; Eric Denes; Philippe Vignon
Journal:  Crit Care Res Pract       Date:  2010-05-26

3.  Leptospirosis in Reunion Island (Indian Ocean): analysis of factors associated with severity in 147 confirmed cases.

Authors:  Fabrice Paganin; Arnaud Bourdin; Cécile Dalban; Jean-Paul Courtin; Patrice Poubeau; Gianandrea Borgherini; Alain Michault; Jean-Claude Sally; François Tixier; Robert Genin; Claude Arvin-Berod
Journal:  Intensive Care Med       Date:  2007-07-17       Impact factor: 17.440

4.  Life-threatening hemoptysis in adults with community-acquired pneumonia due to Panton-Valentine leukocidin-secreting Staphylococcus aureus.

Authors:  Véronique Boussaud; Antoine Parrot; Charles Mayaud; Marie Wislez; Martine Antoine; Clément Picard; Françoise Delisle; Jérome Etienne; Jacques Cadranel
Journal:  Intensive Care Med       Date:  2003-08-02       Impact factor: 17.440

Review 5.  Role of Plasmapheresis and Extracorporeal Membrane Oxygenation in the Treatment of Leptospirosis Complicated with Pulmonary Hemorrhages.

Authors:  C L Fonseka; S Lekamwasam
Journal:  J Trop Med       Date:  2018-12-02

Review 6.  Yunnan Baiyao Adjuvant Treatment for Patients with Hemoptysis: A Systematic Review and Meta-Analysis.

Authors:  Yilan Wang; Xiaomin Wang; Hongfang Fu; Shuo Kou; Demei Huang; Zherui Shen; Fei Wang; Zhenxing Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-02-22       Impact factor: 2.629

7.  Pulmonary manifestations of leptospirosis.

Authors:  Sameer Gulati; Anu Gulati
Journal:  Lung India       Date:  2012-10

8.  Hypoxemic Respiratory Failure from Acute Respiratory Distress Syndrome Secondary to Leptospirosis.

Authors:  Shannon M Fernando; Pierre Cardinal; Peter G Brindley
Journal:  Case Rep Crit Care       Date:  2017-10-12

Review 9.  Infectious diseases causing diffuse alveolar hemorrhage in immunocompetent patients: a state-of-the-art review.

Authors:  Felipe Mussi von Ranke; Gláucia Zanetti; Bruno Hochhegger; Edson Marchiori
Journal:  Lung       Date:  2012-11-06       Impact factor: 2.584

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.